NanoString Technologies, the Seattle-based developer of genetic analysis tools, said today it has named William Young as its new executive chairman. Young is the chairman of Cambridge, MA-based Biogen Idec (NASDAQ: [[ticker:BIIB]]]), and formerly was chairman and CEO of Monogram Biosciences, and chief operating officer of Genentech. NanoString is still seeking a permanent CEO to replace Perry Fell, who retains a board seat, according to a company spokeswoman.
Author: Luke Timmerman
Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.
View all posts by Luke Timmerman
